TORONTO, - Juvenile Diabetes Research Foundation (JDRF) Canada has announced the official launch of its large-scale effort to support clinical trials evaluating new treatments and technologies for type 1 diabetes in Canada. The JDRF Canadian Clinical Trial Network (JDRF CCTN) brings together the country's top physicians, scientists, researchers and innovators from leading universities, hospitals and industry to accelerate the development of treatments and a cure for type 1 diabetes and its complications.
Created in partnership with the Government of Canada, funding for the JDRF CCTN came from a commitment of $20 million by the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), with an additional $13.9 million contribution from JDRF. The $33.9 million investment will help accelerate the testing of new technologies and treatments for Canadians and individuals around the world living with type 1 diabetes and its complications.
